Home > > Global Intragastric Balloon Market Report
The Intragastric Balloon market is expected to experience significant growth in the coming years, driven by a number of factors including an increase in obesity rates, rising awareness of the benefits of minimally invasive procedures, and advancements in technology. One of the key drivers of the market is the growing prevalence of obesity. According to the World Health Organization, worldwide obesity has nearly tripled since 1975. This increase in obesity rates has led to a growing demand for weight loss procedures, including intragastric balloon procedures. In addition to the increase in obesity rates, the market is also being driven by a growing awareness of the benefits of minimally invasive procedures. Intragastric balloons are a non-surgical option for weight loss, which can reduce the risks associated with more invasive procedures such as gastric bypass surgery. Advances in technology are also playing a role in the growth of the market. Newer intragastric balloon systems, such as those that are placed endoscopically, are less invasive than traditional systems and have a shorter recovery time. The market for intragastric balloons is highly competitive, with a number of key players operating in the space. Some of the top companies in the market include Allurion Technologies, Apollo Endosurgery, ReShape Medical, and Obalon Therapeutics. Allurion Technologies is known for its Elipse Balloon, a swallowable intragastric balloon that does not require endoscopic placement. The balloon is removed non-surgically through a patient's natural elimination process. Apollo Endosurgery is a global leader in the development of medical devices for bariatric and metabolic procedures. Their ORBERA Intragastric Balloon System is a non-surgical weight loss solution that has been approved for use in over 80 countries. ReShape Medical has developed the ReShape Integrated Dual Balloon System, which is a minimally invasive, non-surgical weight loss solution that is placed endoscopically. Obalon Therapeutics has developed the Obalon Balloon System, a swallowable, gas-filled balloon that is placed endoscopically to aid weight loss. Overall, the intragastric balloon market is expected to continue to grow in the coming years, driven by increasing obesity rates, a growing awareness of the benefits of minimally invasive procedures, and advancements in technology. Companies such as Allurion Technologies, Apollo Endosurgery, ReShape Medical, and Obalon Therapeutics are well-positioned to capitalize on these trends, with a range of innovative products and strong market positions.